As the first doses of the new COVID-19 vaccine are delivered to health care workers and other early recipients, many Americans are eager to know not only when the vaccine will be available to them but also whether they will be able to get it at no cost…
In the issue brief, KFF experts highlight the laws and regulations that are in place to ensure access to free COVID-19 vaccines for individuals regardless of their insurance status and explain how vaccine administration costs will be covered in private…
Congress seems on the verge of finishing a long-delayed COVID-19 relief bill, which will reportedly include neither of the things each party wanted most — for Republicans, liability protections; for Democrats, funding for states and localities. That bill is likely to be tied to a package to fund the federal government for the rest of the fiscal year and, possibly, include a fix for “surprise” medical bills that patients receive when they inadvertently receive care outside their insurance network. Alice Miranda Ollstein of Politico, Rebecca Adams of CQ Roll Call and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner talks to Elizabeth Mitchell, president and CEO of the Pacific Business Group on Health, about the future of employer-provided health insurance.
Persuading vulnerable low-income and ethnic communities hit hard by the coronavirus to take a new vaccine may be challenging. But established local health leaders, like a group in Rochester, Minnesota, may be one answer.
More than half of long-term care residents have cognitive impairment or dementia, raising questions about whether they will understand the details about the fastest and most extensive vaccination effort in U.S. history.
It’s no worse than the flu, and other deadly disinformation about the coronavirus
Some years from now, infants and school-aged children will probably be the mainstay of a universal vaccination program against COVID-19 in the United States. But first, doctors want to be sure that newfangled vaccines won’t harm them.
Even as the federal Food and Drug Administration engaged in intense deliberations ahead of Friday’s authorization of the nation’s first COVID vaccine, and days before the initial doses were to be released, hospitals have been grappling with how to distribute the first scarce shots. Their plans vary broadly.
Hospitals and nursing homes must decide who gets the initial doses as the U.S. heads into the biggest vaccination effort in history. There’s a lot left to figure out.
Even as the Food and Drug Administration nears emergency authorization for the first vaccine to protect against COVID-19, Congress remains at loggerheads over a COVID relief bill that could also provide the funding to fully distribute the vaccines. Meanwhile, President-elect Joe Biden announced the first members of his health team. Joanne Kenen of Politico, Kimberly Leonard of Business Insider and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Mackert of the University of Texas-Austin, an expert on communicating public health information.
